Publications by authors named "Martin Tallman"

Claim this Profile
E
Expert consensus opinion on the management of hairy cell leukemia in elderly patients.
Tamar Tadmor, Judit Demeter, Andrei Fagarasanu, Robert J Kreitman, Sameer A Parikh, Martin S Tallman

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.
Kuo-Kai Chin, Brian J Ball, Yasmin Abaza, Jessica K Altman, Rahul K Thakur, Martin S Tallman

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative strategies for high-risk acute promyelocytic leukemia.
Kuo-Kai Chin, Martin S Tallman

Curr Opin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curing acute promyelocytic leukemia: no boost from immunity needed.
Martin S Tallman

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant.
Susan DeWolf, Jason Kuttiyara, Paola Vinci, Teng Fei, John Slingerland, Martin Tallman

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs.
Hannah Burton, Leora Boussi, David Nemirovsky, Andriy Derkach, Jenna Ciervo, Martin S Tallman

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS.
Martin S Tallman

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
Meira Yisraeli Salman, Alexander R Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Martin S Tallman

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all- retinoic acid.
Wellington F Silva, Haesook T Kim, Maria S Undurraga, Juan R Navarro-Cabrera, Victor Salinas, Martin S Tallman

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMA/VEN treatment modifications and associated outcomes in -mutant AML.
Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav K Gupta, P Dayand Borge, Martin S Tallman

Leuk Lymphoma· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.
Anand P Jillella, Sandra J Lee, Jessica K Altman, Selina M Luger, Martin S Tallman

JAMA Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912.
Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth Paietta, Susan O'Brien, Martin Tallman

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia.
Kuo-Kai Chin, Yannis Valtis, Andriy Derkach, Meira Yisraeli Salman, Leora Boussi, Martin S Tallman

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum, Charles Craddock, Hervé Dombret, Martin S Tallman

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Luísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, Juan Ramon Navarro-Cabrera, Victor Salinas, Martin Tallman

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia variant and WHO classification correspondence Re: 5 edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Martin S Tallman

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, Elisabeth M Paietta, Kathryn G Roberts, Martin S Tallman

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland B Walter, Chatchada Karanes

J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.
B Bishal Paudel, Su-Fern Tan, Todd E Fox, Johnson Ung, Upendarrao Golla, Martin S Tallman

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution in treatment of acute promyelocytic leukemia: a major victory.
Martin S Tallman

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.
Despoina Papazoglou, Xin Victoria Wang, Tait D Shanafelt, Connie E Lesnick, Nikolaos Ioannou, Martin S Tallman

Blood· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Karthik Nath, Jasme Lee, Theresa A Elko, Lauren Levy, Elaina Preston, Martin S Tallman

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to avoid early mortality in acute promyelocytic leukemia.
Oluwatobi Odetola, Martin S Tallman

Hematology Am Soc Hematol Educ Program· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
Ryan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S Bowman, Martin Tallman

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
Jae H Park, Sean Devlin, Benjamin H Durham, Eric S Winer, Scott Huntington, Martin S Tallman

NEJM Evid· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis